Search for Clinical Trial Results
Glucagonoma - 50 Studies Found
Status | Study |
Completed |
Study Name: Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Condition: Cancer Date: 2007-10-01 Interventions:
|
Terminated |
Study Name: Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors Condition:
|
Terminated |
Study Name: Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors Condition:
|
Completed |
Study Name: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Condition:
|
Completed |
Study Name: Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery Condition:
|
Active, not recruiting |
Study Name: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condition:
|
Withdrawn |
Study Name: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors Condition:
|
Recruiting |
Study Name: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors Condition:
|
Terminated |
Study Name: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Condition:
|
Active, not recruiting |
Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Condition:
|